CWM
ALNY icon

CIBC World Markets’s Alnylam Pharmaceuticals ALNY Stock Holding History

CIBC World Markets’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$4.36M Buy
+10,965
New +$4.85M 0.02% 428
2025
Q2 		$1.77M Sell
5,417
-451
-8% -$125K 0.01% 589
2025
Q1 		$1.58M Buy
5,868
+58
+1% +$14.9K 0.01% 557
2024
Q4 		$1.37M Sell
5,810
-1,561
-21% -$411K 0.01% 586
2024
Q3 		$2.03M Buy
7,371
+553
+8% +$144K 0.01% 523
2024
Q2 		$1.66M Buy
6,818
+1,680
+33% +$265K 0.01% 529
2024
Q1 		$768K Buy
5,138
+1,656
+48% +$276K 0.01% 678
2023
Q4 		$666K Buy
+3,482
New +$593K ﹤0.01% 636
2017
Q1 		– Sell
-210,000
Closed -$7.86M – 613
2016
Q4 		$7.86M Buy
+210,000
New +$8.79M 0.08% 189

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

CIBC World Markets's ALNY Position: Q4 2025 in Review

CIBC World Markets opened a new position in Alnylam Pharmaceuticals (ALNY) in Q4 2025: 10,965 shares worth $4.36M. The stake represents 0.02% of the portfolio and ranks #428 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in ALNY as recently as Q2 2025.

CIBC World Markets first reported a position in ALNY in Q4 2016 and has held it in 9 quarters since. The position peaked at $7.86M in Q4 2016. 848 funds tracked by Wall St. Rank hold ALNY as of Q4 2025.

  • CIBC World Markets held 10,965 shares of Alnylam Pharmaceuticals worth $4.36M as of Q4 2025.
  • Alnylam Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • Alnylam Pharmaceuticals made up 0.02% of CIBC World Markets's portfolio in Q4 2025, its #428 holding.
  • CIBC World Markets first reported a position in Alnylam Pharmaceuticals in Q4 2016 and has held it in 9 quarters since.
  • CIBC World Markets's Alnylam Pharmaceuticals position peaked at $7.86M in Q4 2016.
  • 848 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.